Bilateral adrenal hyperplasia; a common cause of drug-refractory hypertension yet amenable to medical treatment

  • El-Reshaid Kamel Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait
  • Shaikha Al-Bader Department of Medicine, Nephrology unit, Amiri hospital, Ministry of health, Kuwait

Abstract

Over the past 4 and 1/2 years, a total of 97 patients had hypertension yet lacked clinical, laboratory and radiological evidence of renal, renovascular and endocrine disease were investigated for A/R ratio.  High A/R was detected in 30 patients.  Five patients had unilateral adrenal adenoma and 1 had cancer while 24 patients (24.7%) had bilateral enlargements indicating bilateral adrenal hyperplasia (BAH).  Our study has shown that BAH is: (a) easily diagnosed with a combination of A/R ratio and CT scan of the adrenal gland, (b) responsible for 24.7% of hypertension cases, (c) associated with moderate to severe hypertension that may require 2-4 antihypertensives, (d) associated with hypokalemia in only in 54% of the cases, (e) not controlled with a single daily dose of Spironolactone (S) and ½ the cases require 50 mg/day.   Moreover, it has shown that S treatment was not associated with significant hyperkalemia yet gynecomastia and erectile dysfunction were common side effects.  Interestingly; and despite normalization of A/R ratio, most patients continue to require antihypertensive drugs though the number and dosage were less.  The latter phenomenon was more evident in those with higher initial A/R ratio and longer duration of hypertension.  Nephroangiosclerosis is the most plausible explanation for it.  In conclusion; BAH is not a rare disease and should be considered in cases of refractory hypertension. 


Keywords: Aldosterone, Aldosterone/Renin ratio, hypertension, Spironolactone.

Keywords: Aldosterone, Aldosterone/Renin ratio, hypertension, Spironolactone., Aldosterone, Aldosterone/Renin ratio, hypertension, Spironolactone

Downloads

Download data is not yet available.

Author Biographies

El-Reshaid Kamel, Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait

Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait

Shaikha Al-Bader, Department of Medicine, Nephrology unit, Amiri hospital, Ministry of health, Kuwait

Department of Medicine, Nephrology unit, Amiri hospital, Ministry of health, Kuwait

References

1- Schirpebach C, Reincke M. Primary aldosteronism: current knowledge and controversies in Conn’s syndrome. Nature Clin Pract Endocrinol Met 2007; 3: 220-227.
2- Kronenberg HM. Williams textbook of endocrinology (11th ed). Philadelphia: Saunders/Elsevier. ISBN 978-1-4160-2911-3.
3- Nieman LK. Adrenal cortex. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 25th ed. Philadelphia, PA: Elsevier Saunders; 2016:chap 227.
4- Funder, John W.; Carey, Robert M.; Fardella, Carlos; Gomez-Sanchez, Celso E.; Mantero, Franco; Stowasser, Michael; Young, William F.; Montori, Victor M. (2008). "Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism". J Clin Endocrinol Metab 2008; 93: 3266–3281.
5- O’Neil RG. Aldosterone regulation of sodium and potassium transport in the cortical collecting duct. Semin Nephrol 1990; 10: 365-374.
6- Mulatero P, Dluhy RG, Giacchetti G, Boscaro M, Veglio F, Sterwart PM. Diagnosis of primary hyperaldosteronism: from screening to subtype differentiation. Trends Endocrinol Metab 2005; 16: 114-119.
7- Kerstens M, Kobold M, Volmer M, Koerts J, Sluiter W, Dullaart R. Reference values for aldosterone-renin ratio in normotensive individuals and effects of changes in dietary sodium consumption. Clin Chem 2011; 57: 1607-1611.
8- Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol 2015; 31: 569–571.
9- Poulter NR, Prabhakaran D, Caulfield M. "Hypertension". Lancet 2015; 386: 801–812.
10- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure". Hypertension 2003; 42: 1206–1252.
11- Delyani JA, Rocha R, Cook CS, Tobert DS, Levin S, Roniker B, et al. "Eplerenone: a selective aldosterone receptor antagonist (SARA)". Cardiovasc Drug Rev 2001; 19: 185–200.
12- Hill GS. Hypertensive nephroangiosclerosis. Curr Opin Nephrol Hypertens 2008; 17: 266-270.
Statistics
1 Views | 8 Downloads
How to Cite
1.
Kamel E-R, Al-Bader S. Bilateral adrenal hyperplasia; a common cause of drug-refractory hypertension yet amenable to medical treatment. JDDT [Internet]. 15Feb.2020 [cited 27Feb.2020];10(1-s):79-2. Available from: http://jddtonline.info/index.php/jddt/article/view/3862